<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34575615</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>Long COVID-19 Pulmonary Sequelae and Management Considerations.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">838</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm11090838</ELocationID><Abstract><AbstractText>The human coronavirus 2019 disease (COVID-19) and the associated acute respiratory distress syndrome (ARDS) are responsible for the worst global health crisis of the last century. Similarly, to previous coronaviruses leading to past pandemics, including severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS), a growing body of evidence support that a substantial minority of patients surviving the acute phase of the disease present with long-term sequelae lasting for up to 6 months following acute infection. The clinical spectrum of these manifestations is widespread across multiple organs and consists of the long-COVID-19 syndrome. The aim of the current review is to summarize the current state of knowledge on the pulmonary manifestations of the long COVID-19 syndrome including clinical symptoms, parenchymal, and functional abnormalities, as well as highlight epidemiology, risk factors, and follow-up strategies for early identification and timely therapeutic interventions. The literature data on management considerations including the role of corticosteroids and antifibrotic treatment, as well as the therapeutic potential of a structured and personalized pulmonary rehabilitation program are detailed and discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boutou</LastName><ForeName>Afroditi K</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0001-7366-2038</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Medicine, "G. Papanikolaou" Hospital, 57010 Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asimakos</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Critical Care Department and Pulmonary Unit, Evangelismos Hospital, Medical School, National and Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kortianou</LastName><ForeName>Eleni</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Physiotherapy Department, University of Thessaly, 35100 Lamia, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vogiatzis</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-4830-7207</Identifier><AffiliationInfo><Affiliation>Department of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle NE1 8ST, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzouvelekis</LastName><ForeName>Argyris</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University Hospital of Patras, 26504 Patras, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Post-COVID sequelae</Keyword><Keyword MajorTopicYN="N">functional limitation</Keyword><Keyword MajorTopicYN="N">parenchymal abnormalities</Keyword><Keyword MajorTopicYN="N">rehabilitation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34575615</ArticleId><ArticleId IdType="pmc">PMC8469288</ArticleId><ArticleId IdType="doi">10.3390/jpm11090838</ArticleId><ArticleId IdType="pii">jpm11090838</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Boutou A.K., Georgopoulou A., Pitsiou G., Stanopoulos I., Kontakiotis T., Kioumis I. Changes in the respiratory function of COVID-19 survivors during follow-up: A novel respiratory disorder on the rise? Int. J. Clin. Pr. 2021:e14301. doi: 10.1111/ijcp.14301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14301</ArticleId><ArticleId IdType="pmc">PMC8236973</ArticleId><ArticleId IdType="pubmed">33932073</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehar S., Boushra M., Ntiamoah P., Biehl M. Post-acute sequelae of SARS-CoV-2 infection: Caring for the &#x2018;long-haulers&#x2019;. Clevel. Clin. J. Med. 2021;88:267&#x2013;272. doi: 10.3949/ccjm.88a.21010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.88a.21010</ArticleId><ArticleId IdType="pubmed">33941600</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. National Institute for Health and Care Excellence; London, UK: 2020.  [(accessed on 1 June 2021)]. National Institute for Health and Care Excellence: Clinical Guidelines. Available online:  www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of covid-19: Summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.W., Shah A.S., Johnston J.C., Carlsten C., Ryerson C.J. Patient-reported outcome measures after COVID-19: A prospective cohort study. Eur. Respir. J. 2020;56:2003276. doi: 10.1183/13993003.03276-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03276-2020</ArticleId><ArticleId IdType="pmc">PMC7530908</ArticleId><ArticleId IdType="pubmed">33008936</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunninghake G.M. Interstitial lung abnormalities: Erecting fences in the path towards advanced pulmonary fibrosis. Thorax. 2019;74:506&#x2013;511. doi: 10.1136/thoraxjnl-2018-212446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2018-212446</ArticleId><ArticleId IdType="pmc">PMC6475107</ArticleId><ArticleId IdType="pubmed">30723182</ArticleId></ArticleIdList></Reference><Reference><Citation>Spagnolo P., Balestro E., Aliberti S., Cocconcelli E., Biondini D., Casa G.D., Sverzellati N., Maheret T.M. Pulmonary fibrosis secondary to COVID-19: A call to arms? Lancet Respir. Med. 2020;8:750&#x2013;752. doi: 10.1016/S2213-2600(20)30222-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30222-8</ArticleId><ArticleId IdType="pmc">PMC7228737</ArticleId><ArticleId IdType="pubmed">32422177</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall K.J., Mukherjee B., Castanheira A.M., Lam J.L., Benedetti G., Mak S.M., Preston R., Thillai M., Dewar A., Molyneaux P.L., et al. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment. Ann. Am. Thorac. Soc. 2021;18:799&#x2013;806. doi: 10.1513/AnnalsATS.202008-1002OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202008-1002OC</ArticleId><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Li J., Liu H., Han N., Ju J., Kou Y., Chen L., Jiang M., Pan F., Zheng Y., et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: A 15-year follow-up from a prospective cohort study. Bone Res. 2020;8:8. doi: 10.1038/s41413-020-0084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41413-020-0084-5</ArticleId><ArticleId IdType="pmc">PMC7018717</ArticleId><ArticleId IdType="pubmed">32128276</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan O. Long-term sequelae following previous coronavirus epidemics. Clin. Med. 2021;21:e68&#x2013;e70. doi: 10.7861/clinmed.2020-0204.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0204</ArticleId><ArticleId IdType="pmc">PMC7850177</ArticleId><ArticleId IdType="pubmed">33144403</ArticleId></ArticleIdList></Reference><Reference><Citation>Das K.M., Lee E.Y., Singh R., Enani M.A., Al Dossari K., Van Gorkom K., Larsson S.L., Langer R.D. Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J. Radiol. Imaging. 2017;27:342&#x2013;349. doi: 10.4103/ijri.IJRI_469_16.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijri.IJRI_469_16</ArticleId><ArticleId IdType="pmc">PMC5644332</ArticleId><ArticleId IdType="pubmed">29089687</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X., Fan Y., Alwalid O., Li N., Jia X., Yuan M., Li Y., Cao Y., Gu J., Wu H., et al. Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia. Radiology. 2021;299:E177&#x2013;E186. doi: 10.1148/radiol.2021203153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021203153</ArticleId><ArticleId IdType="pmc">PMC7841877</ArticleId><ArticleId IdType="pubmed">33497317</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;s-Telles A., L&#xf3;pez-Romero S., Figueroa-Hurtado E., Pou-Aguilar Y.N., Wong A.W., Milne K.M., Ryerson C.J., Guenette J.A. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir. Physiol. Neurobiol. 2021;288:103644. doi: 10.1016/j.resp.2021.103644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2021.103644</ArticleId><ArticleId IdType="pmc">PMC7910142</ArticleId><ArticleId IdType="pubmed">33647535</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A.S., Wong A.W., Hague C.J., Murphy D.T., Johnston J.C., Ryerson C.J., Carlsten C. A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. 2021;76:402&#x2013;404. doi: 10.1136/thoraxjnl-2020-216308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216308</ArticleId><ArticleId IdType="pubmed">33273023</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells A.U., Devaraj A., Desai S.R. Interstitial Lung Disease after COVID-19 Infection: A Catalog of Uncertainties. Radiology. 2021;299:E216&#x2013;E218. doi: 10.1148/radiol.2021204482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021204482</ArticleId><ArticleId IdType="pmc">PMC7841875</ArticleId><ArticleId IdType="pubmed">33502279</ArticleId></ArticleIdList></Reference><Reference><Citation>Karampitsakos T., Akinosoglou K., Papaioannou O., Panou V., Koromilias A., Bakakos P., Loukides S., Bouros D., Gogos C., Tzouvelekis A. Increased Red Cell Distribution Width Is Associated With Disease Severity in Hospitalized Adults With SARS-CoV-2 Infection: An Observational Multicentric Study. Front. Med. 2020;7:616292. doi: 10.3389/fmed.2020.616292.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.616292</ArticleId><ArticleId IdType="pmc">PMC7759673</ArticleId><ArticleId IdType="pubmed">33363191</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Zhou H., Zhou Y., Wu X., Zhao Y., Lu Y., Tan W., Yuan M., Ding X., Zou J., et al. Risk factors associated with disease severity and length of hospital stay in COVID-19 patients. J. Infect. 2020;81:e95&#x2013;e97. doi: 10.1016/j.jinf.2020.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.04.008</ArticleId><ArticleId IdType="pmc">PMC7162771</ArticleId><ArticleId IdType="pubmed">32305490</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake T.M., Docherty A.B., Harrison E.M., Quint J.K., Adamali H., Agnew S., Babu S., Barber C.M., Barratt S., Bendstrup E., et al. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study. Am. J. Respir. Crit. Care Med. 2020;202:1656&#x2013;1665. doi: 10.1164/rccm.202007-2794OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202007-2794OC</ArticleId><ArticleId IdType="pmc">PMC7737581</ArticleId><ArticleId IdType="pubmed">33007173</ArticleId></ArticleIdList></Reference><Reference><Citation>George P.M., Barratt S.L. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020;75:1009&#x2013;1016. doi: 10.1136/thoraxjnl-2020-215314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215314</ArticleId><ArticleId IdType="pubmed">32839287</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., Beaufils E., Bourbao-Tournois C., Laribi S., Flament T., Ferreira-Maldent N., Bruy&#xe8;re F., Stefic K., et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 2021;27:258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L., Linsell L., Staplin N., Brightling C., Ustianowski A., Elmahi E., et al. Dexamethasone in Hospitalized Patients with Covid-19. N. Engl. J. Med. 2021;384:693&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghu G., Anstrom K.J., King T.E., Jr., Lasky J.A., Martinez F.J. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N. Engl. J. Med. 2012;366:1968&#x2013;1977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3422642</ArticleId><ArticleId IdType="pubmed">22607134</ArticleId></ArticleIdList></Reference><Reference><Citation>Cano E.J., Fonseca Fuentes X., Corsini Campioli C., O&#x2019;Horo J.C., Abu Saleh O., Odeyemi Y., Yadav H., Temesgen Z. Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes: Systematic Review and Meta-analysis. Chest. 2021;159:1019&#x2013;1040. doi: 10.1016/j.chest.2020.10.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.10.054</ArticleId><ArticleId IdType="pmc">PMC7598533</ArticleId><ArticleId IdType="pubmed">33129791</ArticleId></ArticleIdList></Reference><Reference><Citation>George P.M., Wells A.U., Jenkins R.G. Pulmonary fibrosis and COVID-19: The potential role for antifibrotic therapy. Lancet Respir. Med. 2020;8:807&#x2013;815. doi: 10.1016/S2213-2600(20)30225-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30225-3</ArticleId><ArticleId IdType="pmc">PMC7228727</ArticleId><ArticleId IdType="pubmed">32422178</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaherty K.R., Wells A.U., Cottin V., Devaraj A., Walsh S.L.F., Inoue Y., Richeldi L., Kolb M., Tetzlaff K., Stowasser S., et al. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. N. Engl. J. Med. 2019;381:1718&#x2013;1727. doi: 10.1056/NEJMoa1908681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1908681</ArticleId><ArticleId IdType="pubmed">31566307</ArticleId></ArticleIdList></Reference><Reference><Citation>Distler O., Highland K.B., Gahlemann M., Azuma A., Fischer A., Mayes M.D., Raghu G., Sauter W., Girard M., Alves M., et al. Nintedanib for Systemic Sclerosis&#x2013;Associated Interstitial Lung Disease. N. Engl. J. Med. 2019;380:2518&#x2013;2528. doi: 10.1056/NEJMoa1903076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1903076</ArticleId><ArticleId IdType="pubmed">31112379</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher T.M., Corte T.J., Fischer A., Kreuter M., Lederer D.J., Molina-Molina M., Axmann J., Kirchgaessler K.-U., Samara K., Gilberget F., et al. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: A double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir. Med. 2020;8:147&#x2013;157. doi: 10.1016/S2213-2600(19)30341-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(19)30341-8</ArticleId><ArticleId IdType="pubmed">31578169</ArticleId></ArticleIdList></Reference><Reference><Citation>Karampitsakos T., Torrisi S., Antoniou K., Manali E., Korbila I., Papaioannou O., Sampsonas F., Katsaras M., Vasarmidi E., Papakosta D., et al. Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis. Respir. Res. 2021;22:140. doi: 10.1186/s12931-021-01725-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-021-01725-9</ArticleId><ArticleId IdType="pmc">PMC8097815</ArticleId><ArticleId IdType="pubmed">33952261</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler S.A., Ebner L., Aubry-Beigelman C., Bridevaux P.-O., Brutsche M., Clarenbach C., Garzoni C., Geiser T.K., Lenoir A., Mancinetti M., et al. Pulmonary function and radiological features 4 months after COVID-19: First results from the national prospective observational Swiss COVID-19 lung study. Eur. Respir. J. 2021;57:2003690. doi: 10.1183/13993003.03690-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03690-2020</ArticleId><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Tan C., Wu J., Chen M., Wang Z., Luo L., Zhou X., Liu X., Huang X., Yuan S., et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir. Res. 2020;21:163. doi: 10.1186/s12931-020-01429-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01429-6</ArticleId><ArticleId IdType="pmc">PMC7323373</ArticleId><ArticleId IdType="pubmed">32600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X., Jian W., Su Z., Chen M., Peng H., Peng P., Lei C., Chen R., Zhong N., Li S. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur. Respir. J. 2020;55:2001217. doi: 10.1183/13993003.01217-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01217-2020</ArticleId><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>You J., Zhang L., Ni-Jia-Ti M.-Y.-D.-L., Zhang J., Hu F., Chen L., Dong Y., Yang K., Zhang B., Zhang S. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge. J. Infect. 2020;81:e150&#x2013;e152. doi: 10.1016/j.jinf.2020.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.06.003</ArticleId><ArticleId IdType="pmc">PMC7273134</ArticleId><ArticleId IdType="pubmed">32512021</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H., Patel K., Greenwood D., Halpin S., Lewthwaite P., Salawu A., Eyre L., Breen A., O&#x2019;Connor R., Jones A., et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J. Rehabil. Med. 2020;52:jrm00063. doi: 10.2340/16501977-2694.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2694</ArticleId><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K., Zhang W., Yang Y., Zhang J., Li Y., Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement. Ther. Clin. Pract. 2020;39:101166. doi: 10.1016/j.ctcp.2020.101166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctcp.2020.101166</ArticleId><ArticleId IdType="pmc">PMC7118596</ArticleId><ArticleId IdType="pubmed">32379637</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Cassar M.P., Tunnicliffe E.M., Filippini N., Griffanti L., Alfaro-Almagro F., Okell T., Sheerin F., Xie C., Mahmod M., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683. doi: 10.1016/j.eclinm.2020.100683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y., Chen R., Geng Q., Mo X., Zhan C., Jian W., Li S., Zheng J. Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients. Eur. Respir. J. 2021;57:2004265. doi: 10.1183/13993003.04265-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.04265-2020</ArticleId><ArticleId IdType="pmc">PMC7758779</ArticleId><ArticleId IdType="pubmed">33361097</ArticleId></ArticleIdList></Reference><Reference><Citation>Baratto C., Caravita S., Faini A., Perego G.B., Senni M., Badano L.P., Parati G. Impact of COVID-19 on exercise pathophysiology: A combined cardiopulmonary and echocardiographic exercise study. J. Appl. Physiol. 2021;130:1470&#x2013;1478. doi: 10.1152/japplphysiol.00710.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00710.2020</ArticleId><ArticleId IdType="pmc">PMC8143785</ArticleId><ArticleId IdType="pubmed">33764166</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo R.F., Mondoni M., Parazzini E.M., Pitari F., Brambilla E., Luraschi S., Balbi M., Papa G.F.S., Sotgiu G., Guazzi M., et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur. Respir. J. 2021;58:2100870. doi: 10.1183/13993003.00870-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00870-2021</ArticleId><ArticleId IdType="pmc">PMC8082950</ArticleId><ArticleId IdType="pubmed">33926969</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhakar N.R., Kumar G.K. Mechanisms of sympathetic activation and blood pressure elevation by intermittent hypoxia. Respir. Physiol. Neurobiol. 2010;174:156&#x2013;161. doi: 10.1016/j.resp.2010.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2010.08.021</ArticleId><ArticleId IdType="pmc">PMC3042768</ArticleId><ArticleId IdType="pubmed">20804865</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V., Houben-Wilke S., Burtin C., Posthuma R., Franssen F.M., et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome? ERJ Open Res. 2020;6:00542&#x2013;02020. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Gemelli against COVID-19 Post-Acute Care Study Group Persistent Symptoms in Patients after Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H., Doucet L., Berkani S., Oliosi E., Mallart E., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020;81:e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L., Walshaw C., Kemp S., Corrado J., Singh R., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2021;93:1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Belli S., Balbi B., Prince I., Cattaneo D., Masocco F., Zaccaria S., Bertalli L., Cattini F., Lomazzo A., Negro F.D., et al. Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation. Eur. Respir. J. 2020;56:2002096. doi: 10.1183/13993003.02096-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02096-2020</ArticleId><ArticleId IdType="pmc">PMC7411272</ArticleId><ArticleId IdType="pubmed">32764112</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group. Evans R.A., McAuley H., Harrison E.M., Shikotra A., Singapuri A., Sereno M., Elneima O., Docherty A.B., Lone N.I., et al. Physical, Cognitive and Mental Health Impacts of COVID-19 Following Hospitalisation&#x2014;A Multi-Centre Prospective Cohort Study. medRxiv. 2021 doi: 10.1101/2021.03.22.21254057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.22.21254057</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., McDonald D., Magedson A., Wolf C.R., Chu H.Y. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw. Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Bolton C., Nolan C., Harvey-Dunstan T., Connolly B., Man W., Walker P. Delivering Rehabilitation to Patients Surviving COVID-19 Using an Adapted Pulmonary Rehabilitation Approach&#x2014;BTS Guidance 2020.  [(accessed on 25 March 2021)].  Available online:  https://www.brit-thoracic.org.uk/covid-19/covid-19-resumption-andcontinuation-of-respiratory-services.</Citation></Reference><Reference><Citation>Spruit M.A., Holland A.E., Singh S.J., Tonia T., Wilson K.C., Troosters T. COVID-19: Interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society- and American Thoracic Society-coordinated international task force. Eur. Respir. J. 2020;56:2002197. doi: 10.1183/13993003.02197-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02197-2020</ArticleId><ArticleId IdType="pmc">PMC7427118</ArticleId><ArticleId IdType="pubmed">32817258</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitacca M., Lazzeri M., Guffanti E., Frigerio P., D&#x2019;Abrosca F., Gianola S., Carone M., Paneroni M., Ceriana P., Pasqua F., et al. Italian suggestions for pulmonary rehabilitation in COVID-19 patients recovering from acute respiratory failure: Results of a Delphi process. Monaldi Arch. Chest Dis. 2020;90:385&#x2013;393. doi: 10.4081/monaldi.2020.1444.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/monaldi.2020.1444</ArticleId><ArticleId IdType="pubmed">32573175</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun T., Guo L., Tian F., Dai T., Xing X., Zhao J., Li Q. Rehabilitation of patients with COVID-19. Expert Rev. Respir. Med. 2020;14:1249&#x2013;1256. doi: 10.1080/17476348.2020.1811687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2020.1811687</ArticleId><ArticleId IdType="pubmed">32799694</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Chikhanie Y., Veale D., Schoeffler M., P&#xe9;pin J., Verges S., H&#xe9;rengt F. Effectiveness of pulmonary rehabilitation in COVID-19 respiratory failure patients post-ICU. Respir. Physiol. Neurobiol. 2021;287:103639. doi: 10.1016/j.resp.2021.103639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2021.103639</ArticleId><ArticleId IdType="pmc">PMC7879818</ArticleId><ArticleId IdType="pubmed">33588090</ArticleId></ArticleIdList></Reference><Reference><Citation>Beneficial effects of multi-disciplinary rehabilitation in postacute COVID-19: An observational cohort study. Eur. J. Phys. Rehabil. Med. 2021;57:189&#x2013;198. doi: 10.23736/S1973-9087.21.06549-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S1973-9087.21.06549-7</ArticleId><ArticleId IdType="pubmed">33448756</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Rose E.B., Lindsell C.J., Shapiro N.I., Files D.C., Gibbs K.W., Prekker M.E., Steingrub J.S., Smithline H.A., Gong M.N., et al. Characteristics of Adult Outpatients and Inpatients with COVID-19&#x2014;11 Academic Medical Centers, United States, March&#x2013;May 2020. MMWR. Morb. Mortal. Wkly. Rep. 2020;69:841&#x2013;846. doi: 10.15585/mmwr.mm6926e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6926e3</ArticleId><ArticleId IdType="pmc">PMC7332092</ArticleId><ArticleId IdType="pubmed">32614810</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandotra S., Lovato J., Case D., Bakhru R.N., Gibbs K., Berry M., Files D.C., Morris P.E. Physical Function Trajectories in Survivors of Acute Respiratory Failure. Ann. Am. Thorac. Soc. 2019;16:471&#x2013;477. doi: 10.1513/AnnalsATS.201806-375OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201806-375OC</ArticleId><ArticleId IdType="pmc">PMC6441696</ArticleId><ArticleId IdType="pubmed">30571923</ArticleId></ArticleIdList></Reference><Reference><Citation>Daynes E., Gerlis C., Briggs-Price S., Jones P., Singh S.J. COPD assessment test for the evaluation of COVID-19 symptoms. Thorax. 2021;76:185&#x2013;187. doi: 10.1136/thoraxjnl-2020-215916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215916</ArticleId><ArticleId IdType="pubmed">33148809</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Boon G.J., Barco S., Endres M., Geelhoed J.M., Knauss S., Rezek S.A., Spruit M.A., Vehreschild J., Siegerink B. The Post-COVID-19 Functional Status scale: A tool to measure functional status over time after COVID-19. Eur. Respir. J. 2020;56:2001494. doi: 10.1183/13993003.01494-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemh&#xf6;fer C., Gutenbrunner C., Schiller J., Loudovici-Krug D., Best N., B&#xf6;kel A., Sturm C. Assessment of rehabilitation needs in patients after COVID-19: Development of the COVID-19-rehabilitation needs survey. J. Rehabil. Med. 2021;53:jrm00183. doi: 10.2340/16501977-2818.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2818</ArticleId><ArticleId IdType="pmc">PMC8814869</ArticleId><ArticleId IdType="pubmed">33764478</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T., Sahanic S., Pizzini A., Luger A., Schwabl C., Sonnweber B., Kurz K., Koppelst&#xe4;tter S., Haschka D., Petzer V., et al. Cardiopulmonary recovery after COVID-19: An observational prospective multicentre trial. Eur. Respir. J. 2021;57:2003481. doi: 10.1183/13993003.03481-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03481-2020</ArticleId><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus Disease (COVID-19); National Public Health Organization, Greece.  [(accessed on 25 March 2021)];2021  Available online:  https://eody.gov.gr/en/covid-19/</Citation></Reference><Reference><Citation>Instructions for Cleaning and Disinfecting the Environment of Health Service Areas Exposed to the SARS-CoV-2 Virus; National Public Health Organization, Greece.  [(accessed on 25 March 2021)]; Available online:  https://eody.gov.gr/odigies-gia-ton-katharismo-perivallontos-choron-parochis-ypiresion-ygeias-poy-echoyn-ektethei-ston-io-sars-cov-2/?print=print.</Citation></Reference><Reference><Citation>Needham D.M., Sepulveda K.A., Dinglas V.D., Chessare C.M., Friedman L.A., Bingham C.O., Turnbull A.E. Core Outcome Measures for Clinical Research in Acute Respiratory Failure Survivors. An International Modified Delphi Consensus Study. Am. J. Respir. Crit. Care Med. 2017;196:1122&#x2013;1130. doi: 10.1164/rccm.201702-0372OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201702-0372OC</ArticleId><ArticleId IdType="pmc">PMC5694837</ArticleId><ArticleId IdType="pubmed">28537429</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>